13FPulse
TG

TGTX TG THERAPEUTICS INC

2026Q2 · CUSIP 88322Q108 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
420
Institutions that reported holding it to the SEC
Net increase in holders
+62
Last quarter 358 → now 420
How unusual is that
Top 5%
Stronger buying than 96% of US stocks
What the filings say, in one paragraph

420 funds held TGTX at the end of 2026Q2, up 62 from the quarter before. That is stronger buying than 96.1% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $800M(YoY +76.1%), the P/E is 20.8x, return on equity is 73.1%. TGTX has had 12 buying rushes in its history, and the price moved +12.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=45 2013Q4: holders=43 2014Q1: holders=52 2014Q2: holders=66 2014Q3: holders=66 2014Q4: holders=74 2015Q1: holders=79 2015Q2: holders=89 2015Q3: holders=82 2015Q4: holders=87 2016Q1: holders=83 2016Q2: holders=90 2016Q3: holders=78 2016Q4: holders=91 2017Q1: holders=96 2017Q2: holders=103 2017Q3: holders=100 2017Q4: holders=108 2018Q1: holders=125 2018Q2: holders=129 2018Q3: holders=129 2018Q4: holders=115 2019Q1: holders=111 2019Q2: holders=115 2019Q3: holders=114 2019Q4: holders=134 2020Q1: holders=145 2020Q2: holders=171 2020Q3: holders=177 2020Q4: holders=246 2021Q1: holders=235 2021Q2: holders=235 2021Q3: holders=221 2021Q4: holders=193 2022Q1: holders=180 2022Q2: holders=173 2022Q3: holders=183 2022Q4: holders=199 2023Q1: holders=214 2023Q2: holders=243 2023Q3: holders=235 2023Q4: holders=235 2024Q1: holders=241 2024Q2: holders=259 2024Q3: holders=306 2024Q4: holders=331 2025Q1: holders=371 2025Q2: holders=353 2025Q3: holders=351 2025Q4: holders=351 2026Q1: holders=358 2026Q2: holders=420 -69 -34.5 +0 +34.5 +69 38240441 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 12 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 5%
2025Q1 Top 5% +2.9% -20.2%
2024Q3 Top 5% -5.4% +4.3%
2024Q2 Top 20% +1.4% +39.7%
2023Q2 Top 10% -24.1% +1.9%
2023Q1 Top 20% -27.0% -67.2%
2022Q3 Top 20% +36.8% +113.2%
2020Q4 Top 10% +3.8% -29.5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
192
Change in large funds
+29
Total value they hold
$6.1B
Funds buying for the first time
106
Funds that sold out entirely
44
Price change that quarter
+44.1%
Funds holding puts (bearish)
16
Funds holding calls (bullish)
17

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
20.8
EPS (TTM)
$2.74
EPS YoY
+621.0%
Revenue (TTM)
$0.8B
Revenue YoY
+76.1%
Net margin
55.2%
ROE
73.1%
Debt ratio
63.2%
FCF (TTM)
$17M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.65 2021-12-31: EPS -0.70 2022-03-31: EPS -0.51 2022-06-30: EPS -0.30 2022-09-30: EPS -0.26 2022-12-31: EPS -0.58 2023-03-31: EPS -0.28 2023-06-30: EPS -0.34 2023-09-30: EPS 0.73 2023-12-31: EPS -0.02 2024-03-31: EPS -0.07 2024-06-30: EPS 0.04 2024-09-30: EPS 0.02 2024-12-31: EPS 0.16 2025-03-31: EPS 0.03 2025-06-30: EPS 0.17 2025-09-30: EPS 2.43 2025-12-31: EPS 0.14 2026-03-31: EPS 0.12 2026-06-30: EPS 0.05 0M 120M 240M $M -0.77 0.95 2.67 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 55 9 112 215 2023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-87M-34M20M 20162017201820192020202120222023202420252026
Latest quarter $-18M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.